Table 3.
Adrenergic nuclei | Case number |
||||
---|---|---|---|---|---|
mVTAM8 | mVTAM14 | mVTAM19 | mVTANVTA3 | mVTA + IF +CLiWG8 | |
NE nuclei | |||||
A1 | 4|0 | 2|0 | 0|0 | 1|0 | 26|13 |
A2 | 2|0 | 0|1 | 0|0 | 4|1 | 13|4 |
A5 | 12|15 | 5|7 | 2|0 | 3|2 | 18|19 |
LC | 26|14 | 6|8 | 8|9 | 9|7 | 10|2 |
A7 | 0|1 | 0|0 | 0|0 | 0|0 | 1|1 |
Total | 44|30 | 13|16 | 10|9 | 17|10 | 68|39 |
E nuclei | |||||
C1 | 1|0 | 1|0 | 3|0 | 17|3 | |
C2 | 0|0 | 0|0 | 1|0 | 3|1 | |
C3 | 0|0 | 0|0 | 2|0 | 4|3 | |
Total | 1|0 | 1|0 | 6|0 | 24|7 |
Left-side numbers are ipsilateral to the medial VTA microinjection site, whereas in microinjections that target the IF, RL or CLN (Table 4), the numbers represent the respective hemispheres.